Navigation Links
VIDA Diagnostics Introduces Apollo™
Date:11/2/2010

VANCOUVER, British Columbia, Nov. 2, 2010 /PRNewswire/ -- VIDA Diagnostics, Inc., a leader in quantitative pulmonary image analysis, announces the introduction of its Apollo™ Pulmonary Evaluation Software, a comprehensive quantitative software solution for the analysis of major lung diseases, including COPD, asthma, and lung cancer, at the Chest 2010 meeting in Vancouver, BC.  

Apollo strengthens VIDA's leading quantitative pulmonary solution for lung airway and parenchymal analysis and transforms its use into a high volume, time constrained clinical and clinical trial environment.  Apollo, VIDA's first Microsoft release, has significant algorithmic, workflow and dataflow improvements applicable to clinical pulmonary disease analysis.

"We are excited to introduce our Apollo Pulmonary Evaluation Software as a transformative product for VIDA," says Susan A. Wood, Ph.D., President and CEO of VIDA Diagnostics, Inc. "Apollo advances our quantitative approach to pulmonary disease analysis by incorporating the lessons learned from our quantitative imaging experience through academic and clinical trials, and combines it with productivity and connectivity enhancements essential to its widespread clinical use."

Apollo is currently being clinically evaluated at the University of Wisconsin, and the Iowa Comprehensive Lung Imaging Center (iCLIC) at the University of Iowa where it will be used in ongoing trials to validate image-based COPD and asthma measurements.

"An evidence-based approach at the point of care will become increasingly important to the pulmonary physician in evaluating the extent and change of pulmonary disease," states J. Scott Ferguson, MD, Associate Professor, Pulmonology and Critical Care Medicine, Director of Interventional Pulmonology, University of Wisconsin, Madison. "With Apollo, performing interventions with image-guided procedures by the practicing pulmonologist is now achievable and has great potential to improve patient outcomes."

VIDA Diagnostics is currently exhibiting at Chest 2010 Annual Meeting in Vancouver, BC Booth # 1111.

About VIDA Diagnostics, Inc.

VIDA Diagnostics is a leader in quantitative pulmonary image analysis for the diagnosis and treatment of pulmonary diseases. VIDA Diagnostics develops and commercializes pulmonary applications, establishing quantitative pulmonary imaging in routine clinical practice.  VIDA is an established leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, quantitative measures for diagnosis, interventional therapies and therapeutic response assessment.

Participating in the emerging pulmonary device market that is expected to grow to nearly $3.8 billion by 2011, VIDA's vision is to establish lung quantitative CT methods as the standard of care for diagnosis and staging of chronic lung disease. VIDA was founded by four University of Iowa faculty members, Eric Hoffman, Ph.D., Geoffrey McLennan, M.D., Ph.D., Joseph Reinhardt, Ph.D. and, Milan Sonka, Ph.D.  For more information on VIDA Diagnostics, visit: www.vidadiagnostics.com.


'/>"/>
SOURCE VIDA Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C.
2. Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010
3. Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012
4. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
5. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
6. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
7. Quest Diagnostics and HP Simplify Electronic Health Records for Physician Practices
8. Quest Diagnostics to Release Third Quarter 2010 Financial Results
9. Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
10. Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day
11. Siemens Healthcare Diagnostics Publishes Global Trade Item Numbers (GTINs) for its Entire U.S. Product Line to the GHX Health ConneXion(SM) Data Pool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Ill. , Dec. 5, 2016 For ... score on the 2017 Human Rights Campaign Foundation,s ... The CEI is a national benchmarking tool used to ... bisexual, and transgender (LGBT) employee equality. For ... Survey to help companies gauge their equality efforts, culture ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
(Date:12/5/2016)... , Dec. 5, 2016  Seno Medical Instruments, Inc., ... a new tool to improve the process of diagnosing ... from its European MAESTRO post-market surveillance and clinical follow-up ... Symposium (SABCS) taking place from December 6-10, 2016 ... San Antonio, Texas . Seno ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... ... , ... While James Earl Jones is known for myriad roles on stage ... "Front Page". One of the forthcoming episodes examines mammogram techniques; a very important part ... part due to early detection. Like any other disease, treatments have a much higher ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/4/2016)... , ... December 04, 2016 , ... Responsible dental care ... must brush properly to achieve optimal results. This important necessity inspired an inventor from ... for a way to ensure that people break or avoid bad techniques of brushing ...
Breaking Medicine News(10 mins):